Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-24T14:48:29.985Z Has data issue: false hasContentIssue false
  • English
  • Français

Unresolved Questions About Treatment-Resistant Anxiety Disorders

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein  and
Soraya Seedat
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
CNS Spectrums , Volume 9 , Issue 10 , October 2004 , pp. 715
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Demyttenaere, K, Bruffaerts, R, Posada-Villa, J, et al.Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys. JAMA. 2004;291:2581–2590.Google ScholarPubMed
2.Greenberg, PE, Sisitsky, T, Kessler, RC, et al.The economic burden of the anxiety disorders in the 1990s. J Clin Psychiatry. 1999;60:427–435.CrossRefGoogle ScholarPubMed
3.Mogotsi, M, Kaminer, D, Stein, DJ. Quality of life in the anxiety disorders. Harv Rev Psychiatry. 2000;8:273–282.CrossRefGoogle ScholarPubMed
4.Hollander, E, Stein, DJ, Broatch, J, Himelein, C, Rowland, C. A pharmacoeconomic and quality of life study of obsessive-compulsive disorder. CNS Spectr. 1997;2:16–25.CrossRefGoogle Scholar
5.Ballenger, JC, Davidson, JA, Lecrubier, Y, et al.Consensus statement on social anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry. 1998;59:54–60.Google Scholar
6.Ballenger, JC. Treatment of anxiety disorders to remission. J Clin Psychiatry. 2001;62(suppl 12):5–9.Google ScholarPubMed
7.Pallanti, S, Hollander, E, Bienstock, C, et al.Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol. 2002;5:181–191.CrossRefGoogle ScholarPubMed
8.Lochner, C, Stein, DJ. Heterogeneity of obsessive-compulsive disorder: a literature review. Harv Rev Psychiatry. 2003;11:113–132.CrossRefGoogle ScholarPubMed
9.McDougle, CJ, Goodman, WK, Leckman, JFHaloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302–308.CrossRefGoogle ScholarPubMed
10.Graybiel, AM, Rauch, SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron. 2000;28:343–347.CrossRefGoogle Scholar